Anti-neutrophil cytoplasmic antibody (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Anti-neutrophil cytoplasmic antibody" in English language version.

refsWebsite

Global rank English rank

23nih.gov

4^th place

19doi.org

2^nd place

4semanticscholar.org

11^th place

8^th place

3handle.net

102^nd place

76^th place

1bmj.com

1,226^th place

1,421^st place

1harvard.edu

18^th place

17^th place

1hokudai.ac.jp

6,163^rd place

7,269^th place

1web.archive.org

1^st place

1chemocentryx.com

low place

1bloodjournal.org

low place

bloodjournal.org

Jennette JC, Hoidal JR, Falk RJ (Jun 1, 1990). "Specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3". Blood. 75 (11): 2263–4. doi:10.1182/blood.V75.11.2263.2263. PMID 2189509.

bmj.com

ard.bmj.com

Robson JC (2022). "2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis". Annals of the Rheumatic Diseases. 81 (3): 315–320. doi:10.1136/annrheumdis-2021-221795. hdl:1983/ba2d3ba8-c9a1-4606-a765-459e1eb54e36. PMID 35110333. Retrieved 27 September 2023.

chemocentryx.com

ir.chemocentryx.com

"ChemoCentryx Announces FDA Approval of Tavneos (avacopan) in ANCA-Associated Vasculitis". ChemoCentryx, Inc. (Press release). 8 October 2021. Archived from the original on 8 October 2021. Retrieved 11 October 2021.

doi.org

Sharma P, Zonozi R, Geetha D (2024). "ANCA-Associated Vasculitis". Advances in Kidney Disease and Health. 31 (3): 194–205. doi:10.1053/j.akdh.2024.04.005. PMID 39004459.
Savige J, Davies, D, Falk, RJ, Jennette, JC, Wiik, A (Mar 2000). "Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features". Kidney International. 57 (3): 846–62. doi:10.1046/j.1523-1755.2000.057003846.x. PMID 10720938. S2CID 14521707.
Reumaux D, Duthilleul P, Roos D (2004). "Pathogenesis of diseases associated with antineutrophil cytoplasm autoantibodies". Hum Immunol. 65 (1): 1–12. doi:10.1016/j.humimm.2003.09.013. PMID 14700590.
Robson JC (2022). "2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis". Annals of the Rheumatic Diseases. 81 (3): 315–320. doi:10.1136/annrheumdis-2021-221795. hdl:1983/ba2d3ba8-c9a1-4606-a765-459e1eb54e36. PMID 35110333. Retrieved 27 September 2023.
Suppiah R, Robson JC, Grayson PC, Ponte C, Craven A, Khalid S, et al. (2022). "2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis". Annals of the Rheumatic Diseases. 81 (3): 321–326. doi:10.1136/annrheumdis-2021-221796. hdl:1983/129ff4b5-ffde-474d-abc0-339895d912d9. PMID 35110332.
Bossuyt X (February 2006). "Serologic markers in inflammatory bowel disease". Clinical Chemistry. 52 (2): 171–81. doi:10.1373/clinchem.2005.058560. PMID 16339302.
Omura T (September 2019). "Oldest-old type 1 diabetes patient receiving insulin pump treatment with positive myeloperoxidase-antineutrophil cytoplasmic antibody complication: A case report". Geriatrics & Gerontology International. 19 (9): 957–58. doi:10.1111/ggi.13683. PMID 31490005. S2CID 201845957.
Tran H, Tan D, Marnejon TP (February 2013). "Cutaneous vasculopathy associated with levamisole-adulterated cocaine". Clinical Medicine & Research. 11 (1): 26–30. doi:10.3121/cmr.2012.1085. PMC 3573092. PMID 22723468.
Sinclair D, Stevens, JM (Sep 2007). "Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies in the diagnosis and monitoring of systemic vasculitides". Annals of Clinical Biochemistry. 44 (Pt 5): 432–42. doi:10.1258/000456307781646049. PMID 17761028. S2CID 28849057.
Maverakis E, Kim K, Shimoda M, Gershwin M, Patel F, Wilken R, et al. (2015). "Glycans in the immune system and The Altered Glycan Theory of Autoimmunity". J Autoimmun. 57 (6): 1–13. doi:10.1016/j.jaut.2014.12.002. PMC 4340844. PMID 25578468.
Falk RJ, Jennette, JC (May 2010). "ANCA disease: where is this field heading?". Journal of the American Society of Nephrology. 21 (5): 745–52. doi:10.1681/ASN.2009121238. PMID 20395376.
Seo P, Stone, JH (Jul 1, 2004). "The antineutrophil cytoplasmic antibody-associated vasculitides". The American Journal of Medicine. 117 (1): 39–50. doi:10.1016/j.amjmed.2004.02.030. PMID 15210387.
Jennette JC, Xiao, H, Falk, RJ (May 2006). "Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies". Journal of the American Society of Nephrology. 17 (5): 1235–42. doi:10.1681/ASN.2005101048. PMID 16624929.
Falk RJ, Terrell RS, Charles LA, Jennette JC (1990). "Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro". Proc Natl Acad Sci U S A. 87 (11): 4115–4119. Bibcode:1990PNAS...87.4115F. doi:10.1073/pnas.87.11.4115. PMC 54058. PMID 2161532.
Nakazawa D, Masuda S, Tomaru U, Ishizu A (February 2019). "Pathogenesis and therapeutic interventions for ANCA-associated vasculitis" (PDF). Nature Reviews Rheumatology. 15 (2): 91–101. doi:10.1038/s41584-018-0145-y. hdl:2115/74654. PMID 30542206. S2CID 54474335.
Jayne DR JR, Ferraro AJ, Chaudhry AN, Brogan P, Salama AD, Smith KG, et al. (2009-07-01). "A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis". Arthritis Rheum. 60 (7): 2156–68. doi:10.1002/art.24637. PMID 19565480.
Hurtado P, Nitschke J, Hurtado-Perez E, Peh C (April 2013). "ANCA reactive B cells and neutrophils cross-talk in the pathogenesis of AAV: A model proposal". La Presse Médicale. 42 (4 Part 2): 720. doi:10.1016/j.lpm.2013.02.256.
Davies DJ, Moran, JE, Niall, JF, Ryan, GB (Aug 28 – Sep 4, 1982). "Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology?". British Medical Journal (Clinical Research Ed.). 285 (6342): 606. doi:10.1136/bmj.285.6342.606. PMC 1499415. PMID 6297657.
Jennette JC, Hoidal JR, Falk RJ (Jun 1, 1990). "Specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3". Blood. 75 (11): 2263–4. doi:10.1182/blood.V75.11.2263.2263. PMID 2189509.

handle.net

hdl.handle.net

Robson JC (2022). "2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis". Annals of the Rheumatic Diseases. 81 (3): 315–320. doi:10.1136/annrheumdis-2021-221795. hdl:1983/ba2d3ba8-c9a1-4606-a765-459e1eb54e36. PMID 35110333. Retrieved 27 September 2023.
Suppiah R, Robson JC, Grayson PC, Ponte C, Craven A, Khalid S, et al. (2022). "2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis". Annals of the Rheumatic Diseases. 81 (3): 321–326. doi:10.1136/annrheumdis-2021-221796. hdl:1983/129ff4b5-ffde-474d-abc0-339895d912d9. PMID 35110332.
Nakazawa D, Masuda S, Tomaru U, Ishizu A (February 2019). "Pathogenesis and therapeutic interventions for ANCA-associated vasculitis" (PDF). Nature Reviews Rheumatology. 15 (2): 91–101. doi:10.1038/s41584-018-0145-y. hdl:2115/74654. PMID 30542206. S2CID 54474335.

harvard.edu

ui.adsabs.harvard.edu

Falk RJ, Terrell RS, Charles LA, Jennette JC (1990). "Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro". Proc Natl Acad Sci U S A. 87 (11): 4115–4119. Bibcode:1990PNAS...87.4115F. doi:10.1073/pnas.87.11.4115. PMC 54058. PMID 2161532.

hokudai.ac.jp

eprints.lib.hokudai.ac.jp

Nakazawa D, Masuda S, Tomaru U, Ishizu A (February 2019). "Pathogenesis and therapeutic interventions for ANCA-associated vasculitis" (PDF). Nature Reviews Rheumatology. 15 (2): 91–101. doi:10.1038/s41584-018-0145-y. hdl:2115/74654. PMID 30542206. S2CID 54474335.

nih.gov

pubmed.ncbi.nlm.nih.gov

Sharma P, Zonozi R, Geetha D (2024). "ANCA-Associated Vasculitis". Advances in Kidney Disease and Health. 31 (3): 194–205. doi:10.1053/j.akdh.2024.04.005. PMID 39004459.
Savige J, Davies, D, Falk, RJ, Jennette, JC, Wiik, A (Mar 2000). "Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features". Kidney International. 57 (3): 846–62. doi:10.1046/j.1523-1755.2000.057003846.x. PMID 10720938. S2CID 14521707.
Reumaux D, Duthilleul P, Roos D (2004). "Pathogenesis of diseases associated with antineutrophil cytoplasm autoantibodies". Hum Immunol. 65 (1): 1–12. doi:10.1016/j.humimm.2003.09.013. PMID 14700590.
Robson JC (2022). "2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis". Annals of the Rheumatic Diseases. 81 (3): 315–320. doi:10.1136/annrheumdis-2021-221795. hdl:1983/ba2d3ba8-c9a1-4606-a765-459e1eb54e36. PMID 35110333. Retrieved 27 September 2023.
Suppiah R, Robson JC, Grayson PC, Ponte C, Craven A, Khalid S, et al. (2022). "2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis". Annals of the Rheumatic Diseases. 81 (3): 321–326. doi:10.1136/annrheumdis-2021-221796. hdl:1983/129ff4b5-ffde-474d-abc0-339895d912d9. PMID 35110332.
Bossuyt X (February 2006). "Serologic markers in inflammatory bowel disease". Clinical Chemistry. 52 (2): 171–81. doi:10.1373/clinchem.2005.058560. PMID 16339302.
Omura T (September 2019). "Oldest-old type 1 diabetes patient receiving insulin pump treatment with positive myeloperoxidase-antineutrophil cytoplasmic antibody complication: A case report". Geriatrics & Gerontology International. 19 (9): 957–58. doi:10.1111/ggi.13683. PMID 31490005. S2CID 201845957.
Tran H, Tan D, Marnejon TP (February 2013). "Cutaneous vasculopathy associated with levamisole-adulterated cocaine". Clinical Medicine & Research. 11 (1): 26–30. doi:10.3121/cmr.2012.1085. PMC 3573092. PMID 22723468.
Sinclair D, Stevens, JM (Sep 2007). "Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies in the diagnosis and monitoring of systemic vasculitides". Annals of Clinical Biochemistry. 44 (Pt 5): 432–42. doi:10.1258/000456307781646049. PMID 17761028. S2CID 28849057.
Stegeman CA (Nov 2005). "Predictive value of antineutrophil cytoplasmic antibodies in small-vessel vasculitis: is the glass half full or half empty?". The Journal of Rheumatology. 32 (11): 2075–7. PMID 16265681.
Maverakis E, Kim K, Shimoda M, Gershwin M, Patel F, Wilken R, et al. (2015). "Glycans in the immune system and The Altered Glycan Theory of Autoimmunity". J Autoimmun. 57 (6): 1–13. doi:10.1016/j.jaut.2014.12.002. PMC 4340844. PMID 25578468.
Falk RJ, Jennette, JC (May 2010). "ANCA disease: where is this field heading?". Journal of the American Society of Nephrology. 21 (5): 745–52. doi:10.1681/ASN.2009121238. PMID 20395376.
Seo P, Stone, JH (Jul 1, 2004). "The antineutrophil cytoplasmic antibody-associated vasculitides". The American Journal of Medicine. 117 (1): 39–50. doi:10.1016/j.amjmed.2004.02.030. PMID 15210387.
Jennette JC, Xiao, H, Falk, RJ (May 2006). "Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies". Journal of the American Society of Nephrology. 17 (5): 1235–42. doi:10.1681/ASN.2005101048. PMID 16624929.
Falk RJ, Terrell RS, Charles LA, Jennette JC (1990). "Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro". Proc Natl Acad Sci U S A. 87 (11): 4115–4119. Bibcode:1990PNAS...87.4115F. doi:10.1073/pnas.87.11.4115. PMC 54058. PMID 2161532.
Nakazawa D, Masuda S, Tomaru U, Ishizu A (February 2019). "Pathogenesis and therapeutic interventions for ANCA-associated vasculitis" (PDF). Nature Reviews Rheumatology. 15 (2): 91–101. doi:10.1038/s41584-018-0145-y. hdl:2115/74654. PMID 30542206. S2CID 54474335.
Jayne DR JR, Ferraro AJ, Chaudhry AN, Brogan P, Salama AD, Smith KG, et al. (2009-07-01). "A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis". Arthritis Rheum. 60 (7): 2156–68. doi:10.1002/art.24637. PMID 19565480.
Davies DJ, Moran, JE, Niall, JF, Ryan, GB (Aug 28 – Sep 4, 1982). "Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology?". British Medical Journal (Clinical Research Ed.). 285 (6342): 606. doi:10.1136/bmj.285.6342.606. PMC 1499415. PMID 6297657.
Jennette JC, Hoidal JR, Falk RJ (Jun 1, 1990). "Specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3". Blood. 75 (11): 2263–4. doi:10.1182/blood.V75.11.2263.2263. PMID 2189509.

ncbi.nlm.nih.gov

Tran H, Tan D, Marnejon TP (February 2013). "Cutaneous vasculopathy associated with levamisole-adulterated cocaine". Clinical Medicine & Research. 11 (1): 26–30. doi:10.3121/cmr.2012.1085. PMC 3573092. PMID 22723468.
Maverakis E, Kim K, Shimoda M, Gershwin M, Patel F, Wilken R, et al. (2015). "Glycans in the immune system and The Altered Glycan Theory of Autoimmunity". J Autoimmun. 57 (6): 1–13. doi:10.1016/j.jaut.2014.12.002. PMC 4340844. PMID 25578468.
Falk RJ, Terrell RS, Charles LA, Jennette JC (1990). "Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro". Proc Natl Acad Sci U S A. 87 (11): 4115–4119. Bibcode:1990PNAS...87.4115F. doi:10.1073/pnas.87.11.4115. PMC 54058. PMID 2161532.
Davies DJ, Moran, JE, Niall, JF, Ryan, GB (Aug 28 – Sep 4, 1982). "Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology?". British Medical Journal (Clinical Research Ed.). 285 (6342): 606. doi:10.1136/bmj.285.6342.606. PMC 1499415. PMID 6297657.

semanticscholar.org

api.semanticscholar.org

Savige J, Davies, D, Falk, RJ, Jennette, JC, Wiik, A (Mar 2000). "Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features". Kidney International. 57 (3): 846–62. doi:10.1046/j.1523-1755.2000.057003846.x. PMID 10720938. S2CID 14521707.
Omura T (September 2019). "Oldest-old type 1 diabetes patient receiving insulin pump treatment with positive myeloperoxidase-antineutrophil cytoplasmic antibody complication: A case report". Geriatrics & Gerontology International. 19 (9): 957–58. doi:10.1111/ggi.13683. PMID 31490005. S2CID 201845957.
Sinclair D, Stevens, JM (Sep 2007). "Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies in the diagnosis and monitoring of systemic vasculitides". Annals of Clinical Biochemistry. 44 (Pt 5): 432–42. doi:10.1258/000456307781646049. PMID 17761028. S2CID 28849057.
Nakazawa D, Masuda S, Tomaru U, Ishizu A (February 2019). "Pathogenesis and therapeutic interventions for ANCA-associated vasculitis" (PDF). Nature Reviews Rheumatology. 15 (2): 91–101. doi:10.1038/s41584-018-0145-y. hdl:2115/74654. PMID 30542206. S2CID 54474335.

web.archive.org

"ChemoCentryx Announces FDA Approval of Tavneos (avacopan) in ANCA-Associated Vasculitis". ChemoCentryx, Inc. (Press release). 8 October 2021. Archived from the original on 8 October 2021. Retrieved 11 October 2021.